A drug target for focal segmental glomerulosclerosis
AUTOR(ES)
Secko, David
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=558165Documentos Relacionados
- Cyclophosphamide in the treatment of focal segmental glomerulosclerosis
- Rituximab Treatment of Adult Patients with Steroid-Resistant Focal Segmental Glomerulosclerosis
- Podocin Inactivation in Mature Kidneys Causes Focal Segmental Glomerulosclerosis and Nephrotic Syndrome
- Focal and Segmental Glomerulosclerosis and Membranous Nephropathy overlapping in a patient with Nephrotic Syndrome: a case report
- NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele